The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China

Abstract Background During the coronavirus disease 2019 (COVID-19) epidemic, due to the traffic blockade and the shortage of medical resources, more and more premature infants could not receive timely and effective ROP screening, which delayed treatment and even caused children blindness. Therefore,...

Full description

Bibliographic Details
Main Authors: Zheng Guo, Nan Ma, Yixuan Wu, Hua Yuan, Wanjun Luo, Lingkong Zeng, Hong Jie, Shilian Li
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Ophthalmology
Subjects:
Online Access:https://doi.org/10.1186/s12886-021-02018-x
_version_ 1818440914777931776
author Zheng Guo
Nan Ma
Yixuan Wu
Hua Yuan
Wanjun Luo
Lingkong Zeng
Hong Jie
Shilian Li
author_facet Zheng Guo
Nan Ma
Yixuan Wu
Hua Yuan
Wanjun Luo
Lingkong Zeng
Hong Jie
Shilian Li
author_sort Zheng Guo
collection DOAJ
description Abstract Background During the coronavirus disease 2019 (COVID-19) epidemic, due to the traffic blockade and the shortage of medical resources, more and more premature infants could not receive timely and effective ROP screening, which delayed treatment and even caused children blindness. Therefore, how to carry out ROP screening safely and effectively during the epidemic was very important and urgent. This study aimed to evaluate the safety and feasibility of ROP screening assisted by telemedicine network during COVID-19 outbreak. Methods This retrospective study was conducted at Wuhan Children’s hospital in Wuhan, China, from January to October, 2020. The measures which were performed to make the ROP screening more safe and effective were summarized and the comparison between ROP screening assisted by telemedicine network in 2020 and usual screening in 2019 were analyzed. Results A total of 267 outpatient infants completed ROP screening. The median gestational age was 32 weeks (30w to 34w) and the median birth weight was 1780 g (1460 g to 2100 g). Meanwhile, 149 (55.8%) out of 267 infants were males. During January to May in 2020, 86 screening appointments were received, among which 67 (77.9%) were from telemedicine platform online. The completing percentage of total online ROP appointments was higher than that of total face-to-face appointments (58.1% VS 22. 1%, P = 0.018). As for the number of infants screened between 2020 and 2019 from Februaryto October, 54 infants completed ROP screening in 2020, which was higher than that (51participants) in 2019 on September. Furthermore, compared with the usual screening in 2019, ROP screening assisted by telemedicine network in 2020 had smaller gestational age (32w VS 33w, p<0.001) and lower birth weight (1780 g VS 1900 g, p = 0.001). However, of the 267 infants screened, 18(6.7%) had ROP while the percentage of ROP screened in 2019 was the same (44[6.7%]). During follow-up, none of medical staffs was infected and no adverse reaction was reported. Conclusions The screening for retinopathy of prematurity assisted by telemedicine network was safe and feasible during the COVID-19 pandemic. Preventive measures before and after screening were very necessary, which could effectively avoid cross infection.
first_indexed 2024-12-14T18:19:56Z
format Article
id doaj.art-d0ef6d35019a4d05afb8543a0ae5d945
institution Directory Open Access Journal
issn 1471-2415
language English
last_indexed 2024-12-14T18:19:56Z
publishDate 2021-06-01
publisher BMC
record_format Article
series BMC Ophthalmology
spelling doaj.art-d0ef6d35019a4d05afb8543a0ae5d9452022-12-21T22:52:06ZengBMCBMC Ophthalmology1471-24152021-06-012111810.1186/s12886-021-02018-xThe safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, ChinaZheng Guo0Nan Ma1Yixuan Wu2Hua Yuan3Wanjun Luo4Lingkong Zeng5Hong Jie6Shilian Li7Department of Ophthalmology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Medical College, Huazhong University of Science & TechnologyDepartment of Ophthalmology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Medical College, Huazhong University of Science & TechnologyDepartment of Ophthalmology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Medical College, Huazhong University of Science & TechnologyDepartment of Ophthalmology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Medical College, Huazhong University of Science & TechnologyDepartment of infection management, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & TechnologyDepartment of neonatology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & TechnologyDepartment of Ophthalmology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Medical College, Huazhong University of Science & TechnologyDepartment of Ophthalmology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Medical College, Huazhong University of Science & TechnologyAbstract Background During the coronavirus disease 2019 (COVID-19) epidemic, due to the traffic blockade and the shortage of medical resources, more and more premature infants could not receive timely and effective ROP screening, which delayed treatment and even caused children blindness. Therefore, how to carry out ROP screening safely and effectively during the epidemic was very important and urgent. This study aimed to evaluate the safety and feasibility of ROP screening assisted by telemedicine network during COVID-19 outbreak. Methods This retrospective study was conducted at Wuhan Children’s hospital in Wuhan, China, from January to October, 2020. The measures which were performed to make the ROP screening more safe and effective were summarized and the comparison between ROP screening assisted by telemedicine network in 2020 and usual screening in 2019 were analyzed. Results A total of 267 outpatient infants completed ROP screening. The median gestational age was 32 weeks (30w to 34w) and the median birth weight was 1780 g (1460 g to 2100 g). Meanwhile, 149 (55.8%) out of 267 infants were males. During January to May in 2020, 86 screening appointments were received, among which 67 (77.9%) were from telemedicine platform online. The completing percentage of total online ROP appointments was higher than that of total face-to-face appointments (58.1% VS 22. 1%, P = 0.018). As for the number of infants screened between 2020 and 2019 from Februaryto October, 54 infants completed ROP screening in 2020, which was higher than that (51participants) in 2019 on September. Furthermore, compared with the usual screening in 2019, ROP screening assisted by telemedicine network in 2020 had smaller gestational age (32w VS 33w, p<0.001) and lower birth weight (1780 g VS 1900 g, p = 0.001). However, of the 267 infants screened, 18(6.7%) had ROP while the percentage of ROP screened in 2019 was the same (44[6.7%]). During follow-up, none of medical staffs was infected and no adverse reaction was reported. Conclusions The screening for retinopathy of prematurity assisted by telemedicine network was safe and feasible during the COVID-19 pandemic. Preventive measures before and after screening were very necessary, which could effectively avoid cross infection.https://doi.org/10.1186/s12886-021-02018-xRetinopathy of prematurityScreeningCOVID-19Telemedicine
spellingShingle Zheng Guo
Nan Ma
Yixuan Wu
Hua Yuan
Wanjun Luo
Lingkong Zeng
Hong Jie
Shilian Li
The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China
BMC Ophthalmology
Retinopathy of prematurity
Screening
COVID-19
Telemedicine
title The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China
title_full The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China
title_fullStr The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China
title_full_unstemmed The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China
title_short The safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during COVID-19 pandemic in Wuhan, China
title_sort safety and feasibility of the screening for retinopathy of prematurity assisted by telemedicine network during covid 19 pandemic in wuhan china
topic Retinopathy of prematurity
Screening
COVID-19
Telemedicine
url https://doi.org/10.1186/s12886-021-02018-x
work_keys_str_mv AT zhengguo thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT nanma thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT yixuanwu thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT huayuan thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT wanjunluo thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT lingkongzeng thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT hongjie thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT shilianli thesafetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT zhengguo safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT nanma safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT yixuanwu safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT huayuan safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT wanjunluo safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT lingkongzeng safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT hongjie safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina
AT shilianli safetyandfeasibilityofthescreeningforretinopathyofprematurityassistedbytelemedicinenetworkduringcovid19pandemicinwuhanchina